Phenotypic and target-based approach to antitubercular drug discovery : investigation of thienopyrimidine and hydantoin scaffolds as new hits against Mycobacterium tuberculosis
Source
Antwerp, University of Antwerp, Faculty of Pharmaceutical, Biomedical and Veterinary Sciences, Department of Pharmaceutical Sciences,iii, 334 p.
Structure-property investigation of new "KetoFAPI" inhibitors of fibroblast activation protein (FAP) : discovery of highly potent, selective compounds with prolonged residence times and promising radiotheranostic potential
Source
Journal of medicinal chemistry - ISSN 0022-2623-68:20 (2025) p. 21739-21765
Biarylacetamides : a novel class of late-stage autophagy inhibitors
Source
Autophagy reports - ISSN 2769-4127-4:1 (2025) p. 1-23
Synthesis and preclinical evaluation of druglike ¹⁸F-labeled fibroblast activation protein (FAP) inhibitors with enhanced tumor retention
Source
Bioconjugate chemistry - ISSN 1043-1802-36:8 (2025) p. 1887-1906
Fibroblast activation protein on human natural killer cells : insights from natural killer cell activation and crosstalk with cancer-associated fibroblasts
Source
Journal of leukocyte biology - ISSN 1938-3673-117:7 (2025) p. 1-18